11 results on '"C. Lorrie Epling"'
Search Results
2. Data from Impact of Two Measures of Micrometastatic Disease on Clinical Outcomes in Patients with Newly Diagnosed Ewing Sarcoma: A Report from the Children's Oncology Group
- Author
-
Steven G. DuBois, Crystal L. Mackall, Stephen L. Lessnick, Richard G. Gorlick, Richard B. Womer, Katherine K. Matthay, Donald A. Barkauskas, Mark D. Krailo, Elizabeth McIlvaine, Phillip Barnette, Katherine A. Janeway, Holcombe E. Grier, Douglas S. Hawkins, Elizabeth Sinclair, C. Lorrie Epling, Jeremy V. Edwards, and Kieuhoa T. Vo
- Abstract
Purpose: Flow cytometry and RT-PCR can detect occult Ewing sarcoma cells in the blood and bone marrow. These techniques were used to evaluate the prognostic significance of micrometastatic disease in Ewing sarcoma.Experimental Design: Newly diagnosed patients with Ewing sarcoma were enrolled on two prospective multicenter studies. In the flow cytometry cohort, patients were defined as “positive” for bone marrow micrometastatic disease if their CD99+/CD45− values were above the upper limit in 22 control patients. In the PCR cohort, RT-PCR on blood or bone marrow samples classified the patients as “positive” or “negative” for EWSR1/FLI1 translocations. The association between micrometastatic disease burden with clinical features and outcome was assessed. Coexpression of insulin-like growth factor-1 receptor (IGF-1R) on detected tumor cells was performed in a subset of flow cytometry samples.Results: The median total bone marrow CD99+CD45− percent was 0.0012% (range 0%–1.10%) in the flow cytometry cohort, with 14 of 109 (12.8%) of Ewing sarcoma patients defined as “positive.” In the PCR cohort, 19.6% (44/225) patients were “positive” for any EWSR1/FLI1 translocation in blood or bone marrow. There were no differences in baseline clinical features or event-free or overall survival between patients classified as “positive” versus “negative” by either method. CD99+CD45− cells had significantly higher IGF-1R expression compared with CD45+ hematopoietic cells (mean geometric mean fluorescence intensity 982.7 vs. 190.9; P < 0.001).Conclusions: The detection of micrometastatic disease at initial diagnosis by flow cytometry or RT-PCR is not associated with outcome in newly diagnosed patients with Ewing sarcoma. Flow cytometry provides a tool to characterize occult micrometastatic tumor cells for proteins of interest. Clin Cancer Res; 22(14); 3643–50. ©2016 AACR.
- Published
- 2023
3. Impact of Two Measures of Micrometastatic Disease on Clinical Outcomes in Patients with Newly Diagnosed Ewing Sarcoma: A Report from the Children's Oncology Group
- Author
-
Katherine K. Matthay, Crystal L. Mackall, Phillip Barnette, Richard B. Womer, Steven G. DuBois, Douglas S. Hawkins, Elizabeth Sinclair, Stephen L. Lessnick, Richard Gorlick, Katherine A. Janeway, Jeremy V. Edwards, Donald A. Barkauskas, Kieuhoa T. Vo, Holcombe E. Grier, C. Lorrie Epling, Mark Krailo, and Elizabeth McIlvaine
- Subjects
Male ,0301 basic medicine ,Oncology ,Cancer Research ,Receptor, IGF Type 1 ,0302 clinical medicine ,Bone Marrow ,Prospective Studies ,Child ,Cancer ,Pediatric ,screening and diagnosis ,medicine.diagnostic_test ,Sarcoma ,Detection ,Haematopoiesis ,medicine.anatomical_structure ,Neoplasm Micrometastasis ,Child, Preschool ,030220 oncology & carcinogenesis ,FLI1 ,Cohort ,Female ,Receptor ,4.2 Evaluation of markers and technologies ,Adult ,medicine.medical_specialty ,Adolescent ,Pediatric Cancer ,Oncology and Carcinogenesis ,CD99 ,Bone Neoplasms ,Sarcoma, Ewing ,12E7 Antigen ,Article ,Flow cytometry ,Young Adult ,03 medical and health sciences ,Rare Diseases ,Clinical Research ,Ewing ,Internal medicine ,medicine ,Humans ,IGF Type 1 ,Oncology & Carcinogenesis ,Preschool ,business.industry ,Infant, Newborn ,Infant ,Newborn ,medicine.disease ,Occult ,030104 developmental biology ,Leukocyte Common Antigens ,Bone marrow ,business - Abstract
Purpose: Flow cytometry and RT-PCR can detect occult Ewing sarcoma cells in the blood and bone marrow. These techniques were used to evaluate the prognostic significance of micrometastatic disease in Ewing sarcoma. Experimental Design: Newly diagnosed patients with Ewing sarcoma were enrolled on two prospective multicenter studies. In the flow cytometry cohort, patients were defined as “positive” for bone marrow micrometastatic disease if their CD99+/CD45− values were above the upper limit in 22 control patients. In the PCR cohort, RT-PCR on blood or bone marrow samples classified the patients as “positive” or “negative” for EWSR1/FLI1 translocations. The association between micrometastatic disease burden with clinical features and outcome was assessed. Coexpression of insulin-like growth factor-1 receptor (IGF-1R) on detected tumor cells was performed in a subset of flow cytometry samples. Results: The median total bone marrow CD99+CD45− percent was 0.0012% (range 0%–1.10%) in the flow cytometry cohort, with 14 of 109 (12.8%) of Ewing sarcoma patients defined as “positive.” In the PCR cohort, 19.6% (44/225) patients were “positive” for any EWSR1/FLI1 translocation in blood or bone marrow. There were no differences in baseline clinical features or event-free or overall survival between patients classified as “positive” versus “negative” by either method. CD99+CD45− cells had significantly higher IGF-1R expression compared with CD45+ hematopoietic cells (mean geometric mean fluorescence intensity 982.7 vs. 190.9; P < 0.001). Conclusions: The detection of micrometastatic disease at initial diagnosis by flow cytometry or RT-PCR is not associated with outcome in newly diagnosed patients with Ewing sarcoma. Flow cytometry provides a tool to characterize occult micrometastatic tumor cells for proteins of interest. Clin Cancer Res; 22(14); 3643–50. ©2016 AACR.
- Published
- 2016
4. Loss of T cell responses following long-term cryopreservation
- Author
-
Jeffery N Martin, Qi Xuan Tan, Rachel E. Owen, Frederick Hecht, Jeffery M. Harris, Mark A. Jacobson, John W. Heitman, Joseph M. McCune, Dale F. Hirschkorn, Brian Custer, Philip J. Norris, Elizabeth Sinclair, Steven G. Deeks, C. Lorrie Epling, and Brinda Emu
- Subjects
Male ,Time Factors ,T-Lymphocytes ,medicine.medical_treatment ,T cell ,Immunology ,Cytomegalovirus ,Apoptosis ,HIV Infections ,Biology ,Peripheral blood mononuclear cell ,Article ,Cryopreservation ,Cell Line ,Interleukin 21 ,medicine ,Humans ,Immunology and Allergy ,Cytotoxic T cell ,Cells, Cultured ,Cell Line, Transformed ,B-Lymphocytes ,HIV ,T lymphocyte ,Coculture Techniques ,Cytokine ,medicine.anatomical_structure ,Acute Disease ,Chronic Disease ,Cytomegalovirus Infections ,CD8 - Abstract
Although cryopreservation of peripheral blood mononuclear cells (PBMC) is a commonly used technique, the degree to which it affects subsequent functional studies has not been well defined. Here we demonstrate that long-term cryopreservation has detrimental effects on T cell IFN-gamma responses in human immunodeficiency virus (HIV) infected individuals. Long-term cryopreservation caused marked decreases in CD4(+) T cell responses to whole proteins (HIV p55 and cytomegalovirus (CMV) lysate) and HIV peptides, and more limited decreases in CD8(+) T cell responses to whole proteins. These losses were more apparent in cells stored for greater than one year compared to less than six months. CD8(+) T cell responses to peptides and peptide pools were well preserved. Loss of both CD4(+) and CD8(+) T cell responses to CMV peptide pools were minimal in HIV-negative individuals. Addition of exogenous antigen presenting cells (APC) did not restore CD4(+) T cell responses to peptide stimulation and partially restored T cell IFN-gamma responses to p55 protein. Overnight resting of thawed cells did not restore T cell IFN-gamma responses to peptide or whole protein stimulation. A selective loss of phenotypically defined effector cells did not explain the decrement of responses, although cryopreservation did increase CD4(+) T cell apoptosis, possibly contributing to the loss of responses. These data suggest that the impact of cryopreservation should be carefully considered in future vaccine and pathogenesis studies. In HIV-infected individuals short-term cryopreservation may be acceptable for measuring CD4(+) and CD8(+) T cell responses. Long-term cryopreservation, however, may lead to the loss of CD4(+) T cell responses and mild skewing of T cell phenotypic marker expression.
- Published
- 2007
5. Antigen-specific T cell responses induced by Towne cytomegalovirus (CMV) vaccine in CMV-seronegative vaccine recipients
- Author
-
Terence Ho, Alexander Carvidi, Raji Bains, Laurie Agrillo, Mark A. Jacobson, Stuart P. Adler, Elizabeth Sinclair, C. Lorrie Epling, Douglas Black, and Barry M. Bredt
- Subjects
Adult ,CD4-Positive T-Lymphocytes ,Male ,Cellular immunity ,Adolescent ,T cell ,Cytomegalovirus ,CD8-Positive T-Lymphocytes ,Lymphocyte Activation ,medicine.disease_cause ,Herpesviridae ,Viral Matrix Proteins ,Cytomegalovirus Vaccines ,Interferon-gamma ,Antigen ,Betaherpesvirinae ,Virology ,medicine ,Humans ,Antigens, Viral ,biology ,virus diseases ,T lymphocyte ,Middle Aged ,Flow Cytometry ,Phosphoproteins ,biology.organism_classification ,Vaccination ,Infectious Diseases ,medicine.anatomical_structure ,Cytomegalovirus Infections ,Immunology ,Female ,CD8 - Abstract
Background Towne cytomegalovirus (CMV) vaccine is safe and immunogenic, though its protective efficacy has yet to be optimized. Objective Describe antigen-specific T cell responses to Towne vaccination. Study design 3000 pfu Towne CMV vaccine were given to 12 CMV-seronegative volunteers. CMV-specific CD4+ and CD8+ T cell proliferation and IFNγ expression were measured by flow cytometry after stimulation with CMV lysate or peptides. Results All vaccinees developed CD4+ and CD8+ T cell proliferation and CD4+ T cell IFNγ responses to multiple CMV antigens, but their CD8+ T cells had low or undetectable IFNγ responses to pp65 peptide pool. The seven HLA-A2+ subjects had higher CD8+ T cell proliferation and IFNγ responses to IE than pp65, and two never developed CD8+ T cell IFNγ responses to pp65. Peak CD4+ T cell IFNγ responses to CMV lysate were lower than values observed in natural CMV seropositives. Initial CD4+ and CD8+ T cell responses to lysate and pp65 waned after 12 months to levels that were lower than those in healthy CMV seropositives, while vaccinees’ CD8+ T cell responses to IE were robust and prolonged. Conclusion Correlating CMV antigen-specific T cell responses with clinical protective efficacy may facilitate future CMV vaccine development.
- Published
- 2006
6. CMV Antigen-Specific CD4+and CD8+T Cell IFNγ Expression and Proliferation Responses in Healthy CMV-Seropositive Individuals
- Author
-
Alexander Carvidi, Douglas Black, Elizabeth Sinclair, Steven Z. Josefowicz, C. Lorrie Epling, Barry M. Bredt, and Mark A. Jacobson
- Subjects
CD4-Positive T-Lymphocytes ,T cell ,Immunology ,Cytomegalovirus ,CD8-Positive T-Lymphocytes ,Biology ,Antibodies, Viral ,Lymphocyte Activation ,Sensitivity and Specificity ,Article ,Interferon-gamma ,Interleukin 21 ,Immune system ,Antigen ,Virology ,medicine ,Humans ,Cytotoxic T cell ,Interferon gamma ,Antigens, Viral ,virus diseases ,medicine.anatomical_structure ,Cytomegalovirus Infections ,biology.protein ,Molecular Medicine ,Antibody ,CD8 ,medicine.drug - Abstract
CMV-specific CD4+ and CD8+ T cell IFNγ expression and proliferation were measured in healthy volunteers by flow cytometry after CMV lysate or CMV pp65 or IE peptide pool stimulation. Cutoff values were set to maximize specificity (i.e., no false positive CMV-seronegatives). Sensitivity (defined as a positive response in CMV-seropositives to at least one of the 3 antigen preparations used) was 100% for CMV-specific CD4+ and CD8+ T cell IFNγ expression and CD4+ T cell proliferation and 95.4% for CMV-specific CD8+ T cell proliferation. All 22 CMV-seropositive individuals had positive responses by at least three of these four measurements. These findings support the concept that a multiplicity of antigen-specific functional immune responses and persistence of robust virus-specific CD4+ T cells are important components of protective immunity in this chronic viral infection.
- Published
- 2004
7. Flow Cytometric Detection of Ewing Sarcoma Cells in Peripheral Blood and Bone Marrow
- Author
-
Steven G. DuBois, C. Lorrie Epling, Katherine K. Matthay, Elizabeth Sinclair, and Juli Teague
- Subjects
Pathology ,medicine.medical_specialty ,CD99 ,CD34 ,Bone Neoplasms ,Sarcoma, Ewing ,12E7 Antigen ,Article ,Flow cytometry ,Antigen ,Antigens, CD ,Bone Marrow ,Biomarkers, Tumor ,Medicine ,Humans ,medicine.diagnostic_test ,Cell adhesion molecule ,business.industry ,Hematology ,medicine.disease ,Flow Cytometry ,Neoplastic Cells, Circulating ,Prognosis ,Peripheral blood ,medicine.anatomical_structure ,Oncology ,Case-Control Studies ,Pediatrics, Perinatology and Child Health ,Leukocyte Common Antigens ,Sarcoma ,Bone marrow ,business ,Cell Adhesion Molecules - Abstract
A new method for detecting circulating Ewing sarcoma cells using flow cytometry is described. This strategy exploits the nearly universal expression of CD99 and the lack of expression of CD45 by Ewing sarcoma cells.Ewing sarcoma cell line A673, peripheral blood mononuclear cells (PBMCs), and bone marrow mononuclear cells (BMMCs) were stained for CD99 and CD45 in order to detect CD99+CD45- cells by flow cytometry. Known quantities of A673 Ewing sarcoma cells were spiked into control PBMCs to test the accuracy of this method. Control PBMCs were evaluated to assess the level of background staining.Flow cytometry was accurate at frequencies as low as one A673 cell per 500,000 PBMCs. The background rate of CD99+CD45- cell detection was low in PBMCs from nine healthy volunteers (median 0.0001% of total cells; range 0-0.00046%) and was further reduced by incorporating stains to exclude dead cells, progenitor cells, and monocytes. In one subject with newly diagnosed localized Ewing sarcoma, CD99+CD45- cells were detected in both blood (0.0021%) and bone marrow (0.048%).Multicolor flow cytometry for CD99+CD45- cells provides a new strategy for detecting circulating Ewing sarcoma cells. Clinical evaluation and validation of this method is ongoing.
- Published
- 2010
8. Safety and immunogenicity of Towne cytomegalovirus vaccine with or without adjuvant recombinant interleukin-12
- Author
-
Laurie Agrillo, Barry M. Bredt, Mark A. Jacobson, Stuart P. Adler, Terence Ho, Elizabeth Sinclair, C. Lorrie Epling, Douglas Black, Raji Bains, Valerie Girling, and Alexander Carvidi
- Subjects
Human cytomegalovirus ,Adult ,Male ,T cell ,medicine.medical_treatment ,T-Lymphocytes ,Cytomegalovirus ,Antibodies, Viral ,Lymphocyte Activation ,Cytomegalovirus Vaccines ,Immune system ,Antigen ,Adjuvants, Immunologic ,medicine ,Humans ,General Veterinary ,General Immunology and Microbiology ,business.industry ,Immunogenicity ,Public Health, Environmental and Occupational Health ,virus diseases ,Middle Aged ,medicine.disease ,Virology ,Interleukin-12 ,Recombinant Proteins ,Infectious Diseases ,medicine.anatomical_structure ,Immunology ,Cytomegalovirus Infections ,Molecular Medicine ,Female ,Cytomegalovirus vaccine ,business ,Adjuvant ,CD8 ,medicine.drug - Abstract
The Towne, human cytomegalovirus (CMV) vaccine is safe and immunogenic but has not prevented infection at doses tested to date. We administered 3000 pfu Towne CMV vaccine, with or without adjuvant recombinant interleukin-12 (rhIL-12), to CMV-seronegative healthy volunteers and then measured CMV gB-specific IgG titers and CMV-specific CD4+ and CD8+ T cell proliferation and IFNgamma expression after stimulation with whole viral lysate and immunodominant peptide CMV antigens. Adjuvant rhIL-12 at doses up to 2 microg were well-tolerated and associated with (1) dose-related increases in peak anti-CMV gB IgG titers (though not in sustained titers), (2) dose-related increases in the weak CMV viral lysate-specific CD4+ T cell proliferation responses induced by vaccine alone after 360 days of follow-up, and (3) decreases in the very robust CMV IE-specific peak CD4+ T cell and Day 360 CD8+ T cell proliferation responses induced by the vaccine alone. Also, qualitative CD8+ T cell IFNgamma responses to stimulation with the immunodominant CMV antigen, pp65, tended to occur more frequently in vaccinees who received 0.5-2.0 microg rhIL-12 compared to lower dose or no rhIL-12. Thus, adjuvant IL-12 may be a promising strategy for improving antibody and T cell immune responses to a CMV vaccine.
- Published
- 2006
9. Flow cytometric quantification of surface IGF-1R and intracellular p-AKT, p-S6, and p-ERK in Ewing sarcoma (EWS) cells
- Author
-
Steven G. DuBois, C. Lorrie Epling, Alice Tan, Katherine K. Matthay, and Elizabeth Sinclair
- Subjects
Cancer Research ,Pathology ,medicine.medical_specialty ,biology ,medicine.diagnostic_test ,Arbitrary unit ,medicine.disease ,Molecular biology ,Peripheral blood mononuclear cell ,Flow cytometry ,medicine.anatomical_structure ,Oncology ,medicine ,biology.protein ,Sarcoma ,Bone marrow ,Antibody ,Cytometry ,Intracellular - Abstract
23 Background: Targeting the IGF-1R pathway has shown preclinical and clinical evidence of activity in EWS. Markers predictive of response to IGF-1R inhibition are required. The aims of the current study were to quantify surface IGF-1R expression and intracellular signaling proteins by flow cytometry. Methods: Flow cytometry for CD99 and CD45 was used to detect bone marrow micrometastatic tumor cells as CD99+CD45- events in patients with localized EWS. Surface IGF-1R was quantified on tumor cells and normal marrow cells using a commercially available antibody. RD-ES EWS cells were spiked into control PBMCs and starved for 1 hour. Cells were then treated with saline control, rapamycin 10 ng/mL, ADW742 5 uM (small molecule IGF-1R inhibitor), or alpha-IR3 0.5 ug/mL (anti-IGF-1R antibody) and levels of pS6, pAKT, and pERK quantified by phospho-flow cytometry 60 minutes later. All results were expressed as the mean fluorescent intensity (MFI) of staining using arbitrary units. Results: We detected bone marrow micrometastatic tumor cells in marrow samples from 16 patients with EWS. We observed heterogeneous levels of IGF-1R tumor cell surface expression between patients (range of IGF-1R MFI = 0 – 3355). IGF-1R levels were higher in CD99+CD45- tumor cells compared to normal marrow cells (mean MFI 840 for CD99+CD45- tumor cells vs.190 for normal marrow cells; p = 0.005). In RD-ES cells spiked into PBMCs, treatment with rapamycin resulted in 1.32 fold increase in pAKT MFI compared to saline control. Treatment with ADW742 or alpha-IR3 did not impact pAKT MFI. Treatment with rapamycin resulted in a 0.52 fold decrease and a 1.20 fold increase in pS6 and pERK, respectively. Treatment with ADW742 or alpha-IR3 each resulted in similar decreases in both pS6 (0.75-0.87 fold) and pERK (0.67-0.82 fold). In PBMCs, modest changes in pS6 in rapamycin treated cells were observed, without changes in pAKT or pERK. Neither ADW742 nor alpha-IR3 modulated pS6, pAKT, or pERK signaling in PBMCs. Conclusions: Flow cytometry detects a range of surface IGF-1R expression on bone marrow micrometastatic EWS cells. Phospho-flow cytometry detects modulation of pAKT, pS6, and pERK in EWS cells treated with IGF-1R or mTOR inhibitors.
- Published
- 2012
10. [Untitled]
- Author
-
Timothy W. Tobery, Barry M. Bredt, Ruth Baydo, Omu Anzala, Rafick Pierre Sekaly, Gailet Alter, Janice Darden, Giuseppe Pantaleo, Alexandre Harari, Nolwenn Nougarede, Sandra A. Calarota, Peter Hayes, Eva Roig, Claire Landry, Miguel Garcia, Aline Rinfret, Maria A. Suni, Mario Roederer, Jennifer Holbrook, Janet Ottinger, Laurie Lamoreaux, Hazel Maila, Clive M. Gray, Jill Gilmour, Lynda G. Tussey, Patricia D'Souza, Elizabeth Sinclair, Sophia El-Bahi, Josephine Birungi, Ian Frank, Marcus Altfeld, Vernon C. Maino, Kara Punt, Josephine H. Cox, Helen Horton, Megan Baker, C. Lorrie Epling, Richard A. Koup, Holden T. Maecker, Jean D. Boyer, Ellen G. Kuta, and Kent J. Weinhold
- Subjects
biology ,medicine.diagnostic_test ,T cell ,Coefficient of variation ,Immunology ,Peripheral blood mononuclear cell ,Molecular biology ,Flow cytometry ,medicine.anatomical_structure ,Antigen ,medicine ,biology.protein ,Antibody ,Cytometry ,Whole blood - Abstract
Cytokine flow cytometry (CFC) or intracellular cytokine staining (ICS) can quantitate antigen-specific T cell responses in settings such as experimental vaccination. Standardization of ICS among laboratories performing vaccine studies would provide a common platform by which to compare the immunogenicity of different vaccine candidates across multiple international organizations conducting clinical trials. As such, a study was carried out among several laboratories involved in HIV clinical trials, to define the inter-lab precision of ICS using various sample types, and using a common protocol for each experiment (see additional files online). Three sample types (activated, fixed, and frozen whole blood; fresh whole blood; and cryopreserved PBMC) were shipped to various sites, where ICS assays using cytomegalovirus (CMV) pp65 peptide mix or control antigens were performed in parallel in 96-well plates. For one experiment, antigens and antibody cocktails were lyophilised into 96-well plates to simplify and standardize the assay setup. Results (CD4+cytokine+ cells and CD8+cytokine+ cells) were determined by each site. Raw data were also sent to a central site for batch analysis with a dynamic gating template. Mean inter-laboratory coefficient of variation (C.V.) ranged from 17–44% depending upon the sample type and analysis method. Cryopreserved peripheral blood mononuclear cells (PBMC) yielded lower inter-lab C.V.'s than whole blood. Centralized analysis (using a dynamic gating template) reduced the inter-lab C.V. by 5–20%, depending upon the experiment. The inter-lab C.V. was lowest (18–24%) for samples with a mean of >0.5% IFNγ + T cells, and highest (57–82%) for samples with a mean of
- Published
- 2005
11. CMV Antigen-Specific CD4+ and CD8+ T Cell IFNγ Expression and Proliferation Responses in Healthy CMV-Seropositive Individuals.
- Author
-
Elizabeth Sinclair, Douglas Black, C. Lorrie Epling, <SUP>3</SUP>, Alexander Carvidi, Steven Z. JosefowicZ, Barry M. Bredt, and Mark A. Jacobson
- Published
- 2004
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.